Amirhossein Bahreyni
Overview
Explore the profile of Amirhossein Bahreyni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
507
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mohamud Y, Bahreyni A, Hwang S, Lin J, Wang Z, Zhang J, et al.
J Virol
. 2025 Jan;
99(2):e0180424.
PMID: 39846741
Importance: This study sheds light on how enteroviruses, specifically coxsackievirus B3, may contribute to heart failure by triggering harmful immune responses in the heart. We discovered that viral infections in...
2.
Mohamud Y, Lin J, Hwang S, Bahreyni A, Wang Z, Luo H
Viruses
. 2024 Sep;
16(9).
PMID: 39339932
Enteroviruses are a genus of small RNA viruses that are responsible for approximately one billion global infections annually. These infections range in severity from the common cold and flu-like symptoms...
3.
Bahreyni A, Saeedi N, Al-Asady A, Soleimani A, Ghorbani E, Khazaei M, et al.
Mol Biol Rep
. 2024 Feb;
51(1):358.
PMID: 38400849
Background: Cardiomyocytes form, transport, and metabolize the omnipresent metabolite adenosine. Depending upon the adenosine concentrations and the pharmacological properties of receptor subtypes, adenosine exerts (patho)physiological responses in the cardiovascular system....
4.
Bahreyni A, Mohamud Y, Luo H
Cancer Lett
. 2024 Feb;
585:216634.
PMID: 38309616
Breast cancer continues to pose significant challenges in the field of oncology, necessitating innovative treatment approaches. Among these, oncolytic viruses have emerged as a promising frontier in the battle against...
5.
Bahreyni A, Mohamud Y, Ashraf Nouhegar S, Zhang J, Luo H
ACS Nano
. 2024 Jan;
18(5):4241-4255.
PMID: 38278522
Breast cancer's immunosuppressive environment hinders effective immunotherapy, but oncolytic viruses hold promise for addressing this challenge by targeting tumor cells and altering the microenvironment. Yet, neutralizing antibodies and immune clearance...
6.
Bahreyni A, Liu H, Mohamud Y, Xue Y, Fan Y, Zhang Y, et al.
BMC Med
. 2023 May;
21(1):193.
PMID: 37226233
Background: Immunotherapy has emerged as an efficient therapeutic approach for cancer management. However, stimulation of host immune system against cancer cells often fails to achieve promising clinical outcomes mainly owing...
7.
Bahreyni A, Mohamud Y, Zhang J, Luo H
Biomed Pharmacother
. 2023 Apr;
163:114789.
PMID: 37119737
There is growing evidence showing that single administration of immunotherapeutic agents has limited efficacy in a number of cancer patients mainly due to tumor heterogeneity and immunosuppressive tumor microenvironment. In...
8.
Mohamud Y, Li B, Bahreyni A, Luo H
Viruses
. 2023 Feb;
15(2).
PMID: 36851568
The myocardium/heart is the most mitochondria-rich tissue in the human body with mitochondria comprising approximately 30% of total cardiomyocyte volume. As the resident "powerhouse" of cells, mitochondria help to fuel...
9.
Bahreyni A, Mohamud Y, Luo H
Biomed Pharmacother
. 2023 Jan;
159:114243.
PMID: 36641926
Melanoma is a malignant tumor that accounts for the deadliest form of skin cancers. Despite the significant efforts made recently for development of immunotherapeutic strategies including using immune checkpoint inhibitors...
10.
Liu H, Bahreyni A, Mohamud Y, Xue Y, Jia W, Luo H
Mol Ther Oncolytics
. 2022 Nov;
27:89-99.
PMID: 36321136
Genetic modification of coxsackievirus B3 (CVB3) by inserting target sequences (TS) of tumor-suppressive and/or organ-selective microRNAs (miRs) into viral genome can efficiently eliminate viral pathogenesis without significant impacts on its...